These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 33909065)
1. The role of cell surface sialic acids for SARS-CoV-2 infection. Sun XL Glycobiology; 2021 Nov; 31(10):1245-1253. PubMed ID: 33909065 [TBL] [Abstract][Full Text] [Related]
2. The structural basis of accelerated host cell entry by SARS-CoV-2†. Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19. Dakal TC Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S Elife; 2020 Oct; 9():. PubMed ID: 33103998 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2. Rowland R; Brandariz-Nuñez A Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876 [TBL] [Abstract][Full Text] [Related]
7. The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint. Guo H; Li A; Lin HF; Liu MQ; Chen J; Jiang TT; Li B; Wang Y; Letko MC; Peng W; Shi ZL J Virol; 2022 Aug; 96(15):e0095822. PubMed ID: 35852351 [TBL] [Abstract][Full Text] [Related]
8. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction. Kim CH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730 [TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2. Nguyen K; Chakraborty S; Mansbach RA; Korber B; Gnanakaran S Viruses; 2021 May; 13(5):. PubMed ID: 34067878 [TBL] [Abstract][Full Text] [Related]
15. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes. Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095 [TBL] [Abstract][Full Text] [Related]
16. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. Qing E; Hantak M; Perlman S; Gallagher T mBio; 2020 Feb; 11(1):. PubMed ID: 32047128 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. Shajahan A; Archer-Hartmann S; Supekar NT; Gleinich AS; Heiss C; Azadi P Glycobiology; 2021 May; 31(4):410-424. PubMed ID: 33135055 [TBL] [Abstract][Full Text] [Related]
18. Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs. Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP J Virol; 2022 Sep; 96(17):e0025622. PubMed ID: 36000847 [TBL] [Abstract][Full Text] [Related]
19. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S J Genet; 2021; 100(1):. PubMed ID: 33707363 [TBL] [Abstract][Full Text] [Related]
20. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface. Villoutreix BO; Calvez V; Marcelin AG; Khatib AM Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]